CMV

Congenital CMV infection is the number 1 cause of nonhereditary sensorineural hearing loss.

Screening for congenital CMV has been an ongoing subject of debate.

Every day in the UK, two to three newborn babies will be born affected by CMV, equivalent to almost 1,000 babies every year.

"It's been 13 years since my daughter Elizabeth died during a seizure at age 16," says Lisa Saunders, leader of the Child Care Providers Education Committee, National CMV Foundation.

This loss creates a permissive environment for CMV reactivation which may approach a frequency of 70 percent when either the recipient or the donor is CMV seropositive.

To prevent CMV infection and disease, transplant centers routinely employ either a prophylactic or preemptive strategy using ganciclovir or its oral prodrug valganciclovir.

The US FDA has granted marketing authorisation of the Alethia CMV Assay Test System to Meridian Bioscience Inc.

Medical College, Tirupati, to explore the seroprevalence of CMV IgM antibodies among antenatal women with bad obstetric history attending the antenatal clinic at Government Maternity Hospital, Tirupathi during the period from July 2011 to December 2011.

Antibodies for CMV were positive for IgG and negative for IgM.

CMV is a common virus that infects as many as 90 per cent of adults in Africa and 70 per cent in the U.S.

While CMV is a relatively rare condition, it is also the most common infectious cause of disability in newborns.

CMV infections outbreak in three types: primary infection, reactivation, and super infection [7].

The common pathogen implicated is Cryptosporidium parvum, while others include Cytomegalovirus (CMV), Microsporidium, and Cyclospora [1, 2].